Alzheimer s & Dementia · 2024 · 75 citations · 30 references
MedicineNeurologyNeuroscienceCognitive NeurologyDementiaNeurodegenerationAlzheimer DiseaseBiomarkers Of NeurodegenerationCognitive ImpairmentDementia BiomarkersDementia DiagnosisTau PathologyAlzheimer's Disease DiagnosisClinical Laboratory EvaluationDiagnostic Accuracy StudiesDiagnostic Testing AccuracyFalse-positive ResultsMild Cognitive Impairment DiagnosisTau Protein Biomarkers
INTRODUCTION: We aimed to evaluate clinical interpretation cutpoints for two plasma phosphorylated tau (p-tau)217 assays (ALZpath and Lumipulse) as predictors of amyloid status for implementation in clinical practice. METHODS: Clinical performance of plasma p-tau217 against amyloid positron emission tomography status was evaluated in participants with mild cognitive impairment or mild dementia (n = 427). RESULTS: Using a one-cutpoint approach (negative/positive), neither assay achieved ≥ 90% in both sensitivity and specificity. A two-cutpoint approach yielding 92% sensitivity and 96% specificity provided the desired balance of false positives and false negatives, while categorizing 20% and 39% of results as indeterminate for the Lumipulse and ALZpath assays, respectively. DISCUSSION: This study provides a systematic framework for selection of assay-specific cutpoints for clinical use of plasma p-tau217 for determination of amyloid status. Our findings suggest that a two-cutpoint approach may have advantages in optimizing diagnostic accuracy while minimizing potential harm from false positive results. HIGHLIGHTS: Phosphorylated tau (p-tau)217 cutpoints for detection of amyloid pathology were established. A two-cutpoint approach exhibited the best performance for clinical laboratory use. p-tau217 assays differed in the percentage of results categorized as intermediate.
30
Guy M. McKhann, David S. Knopman, Howard Chertkow et al. · Alzheimer s & Dementia · 2011 · 18.8K citations · Full text
Index for rating diagnostic tests
W. J. Youden · Cancer · 1950 · 11.5K citations · Full text
Education, Educational Assessment, Educational Measurement +11
Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound‐B
William E. Klunk, Henry Engler, Agneta Nordberg et al. · Annals of Neurology · 2004 · 4.5K citations
Medicine, Neurology, Neuroscience +15